DR. JENNIFER LYNN LIGHTER, M.D.
Hospitals at 1 Ave, New York, NY
License number
New York 228164
Category
Hospitals
Type
Children
Address
Address
550 1St Ave DEPARTMENT PEDIATRICS, New York, NY 10016
Phone
(917) 884-5105
(211) 285-1634
(211) 285-1634
Personal information
See more information about JENNIFER LYNN LIGHTER at radaris.comName
Address
Phone
132 E 72Nd St APT 1, New York, NY 10021
Professional information
Dr. Jennifer L Lighter, New York NY - MD (Doctor of Medicine)
Specialties:
Pediatric Infectious Disease Medicine
Age:
50
Address:
550 1St Ave, New York 10016
(917) 884-5105 (Phone), (212) 263-7300 (Fax)
New York
462 1St Ave, New York 10016
(212) 562-5555 (Phone), (212) 263-7369 (Fax)
550 1St Ave, New York 10016
(917) 884-5105 (Phone), (212) 263-7300 (Fax)
(917) 884-5105 (Phone), (212) 263-7300 (Fax)
New York
462 1St Ave, New York 10016
(212) 562-5555 (Phone), (212) 263-7369 (Fax)
550 1St Ave, New York 10016
(917) 884-5105 (Phone), (212) 263-7300 (Fax)
Languages:
English
Education:
Medical School
George Washington University / School of Medicine And Health Sciences
Graduated: 2001
George Washington University / School of Medicine And Health Sciences
Graduated: 2001
Tuberculosis Vaccine And Method Of Using Same
US Patent:
2013027, Oct 17, 2013
Filed:
Feb 11, 2013
Appl. No.:
13/764241
Inventors:
Jennifer Lighter - New York NY, US
Assignee:
MICO BIO, INC. - New York NY
International Classification:
A61K 39/04, A61K 9/00
US Classification:
4242481
Abstract:
Provided is a pharmaceutical composition that includes one or more inactivated spp., which are preferably inactivated using gamma irradiation, and which is than formulated for mucosal or pulmonary delivery to a subject. The pharmaceutical compositions are useful for preventing or treating mycobacterium-associated infections in a subject, including a human subject.
Tuberculosis Vaccine And Method Of Using Same
US Patent:
2010011, May 6, 2010
Filed:
Apr 11, 2008
Appl. No.:
12/595006
Inventors:
Jennifer Lighter - New York NY, US
Jason Fisher - New York NY, US
Jason Fisher - New York NY, US
International Classification:
A61K 39/04, A61P 31/06
US Classification:
4242481
Abstract:
Provided is a pharmaceutical composition that includes one or more inactivated spp., which are preferably inactivated using gamma irradiation, and which is than formulated for mucosal or pulmonary delivery to a subject. The pharmaceutical compositions are useful for preventing or treating -associated infections in a subject, including a human subject.